Itau Unibanco Holding S.A. Acquires Shares of 116 Stryker Co. (NYSE:SYK)

Itau Unibanco Holding S.A. bought a new stake in Stryker Co. (NYSE:SYK) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 116 shares of the medical technology company’s stock, valued at approximately $42,000.

A number of other large investors have also added to or reduced their stakes in SYK. World Investment Advisors LLC lifted its stake in shares of Stryker by 126.1% in the third quarter. World Investment Advisors LLC now owns 8,142 shares of the medical technology company’s stock worth $2,941,000 after acquiring an additional 4,541 shares in the last quarter. Tidal Investments LLC boosted its stake in shares of Stryker by 13.9% during the 3rd quarter. Tidal Investments LLC now owns 17,478 shares of the medical technology company’s stock valued at $6,314,000 after buying an additional 2,139 shares during the last quarter. Principal Financial Group Inc. grew its position in shares of Stryker by 6.2% during the third quarter. Principal Financial Group Inc. now owns 398,422 shares of the medical technology company’s stock worth $143,934,000 after buying an additional 23,329 shares in the last quarter. Old Port Advisors increased its stake in shares of Stryker by 6.6% in the fourth quarter. Old Port Advisors now owns 996 shares of the medical technology company’s stock worth $359,000 after buying an additional 62 shares during the last quarter. Finally, Versant Capital Management Inc raised its holdings in Stryker by 16.5% in the fourth quarter. Versant Capital Management Inc now owns 1,121 shares of the medical technology company’s stock valued at $404,000 after acquiring an additional 159 shares in the last quarter. 77.09% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have weighed in on SYK shares. The Goldman Sachs Group set a $422.00 price objective on shares of Stryker in a report on Tuesday, March 4th. Stifel Nicolaus upped their price objective on Stryker from $400.00 to $440.00 and gave the company a “buy” rating in a research note on Wednesday, January 29th. Truist Financial lifted their target price on Stryker from $409.00 to $413.00 and gave the stock a “hold” rating in a research report on Thursday, January 30th. JMP Securities reissued a “market perform” rating on shares of Stryker in a research report on Tuesday, February 18th. Finally, BTIG Research set a $403.00 target price on shares of Stryker and gave the company a “buy” rating in a research note on Monday, April 14th. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $426.53.

Stryker Stock Up 1.2 %

Stryker stock opened at $378.60 on Friday. Stryker Co. has a 52 week low of $314.93 and a 52 week high of $406.19. The stock has a market cap of $144.51 billion, a price-to-earnings ratio of 48.79, a PEG ratio of 2.93 and a beta of 0.93. The company’s 50-day moving average price is $366.38 and its two-hundred day moving average price is $373.73. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 0.59.

Stryker (NYSE:SYK) last released its earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, topping analysts’ consensus estimates of $2.73 by $0.11. Stryker had a return on equity of 23.58% and a net margin of 13.25%. The firm had revenue of $5.87 billion during the quarter, compared to the consensus estimate of $5.68 billion. During the same period in the prior year, the firm posted $2.50 earnings per share. The firm’s revenue for the quarter was up 11.9% compared to the same quarter last year. On average, analysts expect that Stryker Co. will post 13.47 EPS for the current fiscal year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st were issued a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 0.89%. The ex-dividend date of this dividend was Monday, March 31st. Stryker’s payout ratio is 45.41%.

Insider Activity

In related news, Director Allan C. Golston sold 2,458 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total transaction of $941,586.06. Following the completion of the sale, the director now directly owns 14,895 shares in the company, valued at approximately $5,705,827.65. This trade represents a 14.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 5.90% of the company’s stock.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.